X0202 4 2008-02-21 0000864268 BRADLEY PHARMACEUTICALS INC NYSE: BDY 0001141771 LENCZYCKI R BRENT 383 ROUTE 46 WEST FAIRFIELD NJ 07004 0 1 0 0 VP - CFO Common Stock 2008-02-21 4 D 0 15000 2 A 27596 D Common Stock 2008-02-21 4 D 0 6000 2.1875 A 33596 D Common Stock 2008-02-21 4 D 0 60000 7.05 A 93596 D Common Stock 2008-02-21 4 D 0 80000 13.41 A 173596 D Common Stock 2008-02-21 4 D 0 12596 20 D 161000 D Common Stock 2008-02-21 4 D 0 80000 20 D 81000 D Common Stock 2008-02-21 4 D 0 15000 20 D 66000 D Common Stock 2008-02-21 4 D 0 60000 20 D 6000 D Common Stock 2008-02-21 4 D 0 6000 20 D 0 D Common Stock 2008-02-21 4 D 0 2545 20 D 0 I 401K Common Stock 2008-02-21 4 D 0 2991 20 D 0 I 401K Match Stock Options (Right to buy) 2 2008-02-21 4 U 0 15000 2 D 2008-02-21 2011-03-29 Common Stock 15000 0 D Stock Options (Right to buy) 2.1875 2008-02-21 4 U 0 6000 2.1875 D 2008-02-21 2008-03-12 Common Stock 6000 0 D Stock Options (Right to buy) 7.05 2008-02-21 4 U 0 60000 7.05 D 2008-02-21 2011-07-08 Common Stock 60000 0 D Stock Options (Right to buy) 10.58 2008-02-21 4 H 0 1265 10.58 D 2008-02-21 2006-07-08 Common Stock 1265 0 D Stock Options (Right to buy) 13.41 2008-02-21 4 U 0 80000 13.41 D 2008-02-21 2015-11-21 Common Stock 80000 0 D The options were tendered in connection with the Tender Offer dated January 17, 2008. Disposed of pursuant to the merger agreement between the Issuer and Phase Merger Sub Inc. in exchange for cash. Expiration date has expired. R.BrentLenczycki 2008-02-21